| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |